These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2896134)

  • 21. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects.
    Giugliano D; Quatraro A; Consoli G; Ceriello A; Torella R; D'Onofrio F
    Metabolism; 1987 Mar; 36(3):286-9. PubMed ID: 3547015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of an enkephalin analogue (DAMME) on pituitary and pancreatic function in sheep.
    Bolton JE; Roud HK; Redekopp C; Livesey JH; Nicholls MG; Donald RA
    Horm Metab Res; 1983 Dec; 15(12):598-601. PubMed ID: 6141131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an enkephalin analogue (DAMME) on insulin release from cultured rat islets of Langerhans.
    Pierluissi R; Pierluissi J; Ashcroft SJ
    Diabetologia; 1981 Jun; 20(6):642-6. PubMed ID: 6790327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man.
    Paolisso G; Giugliano D; Scheen AJ; Franchimont P; D'Onofrio F; Lefèbvre PJ
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):161-9. PubMed ID: 2885994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The regulation of insulin and glucagon secretion by opiates: a study with naloxone in healthy humans.
    Locatelli A; Spotti D; Caviezel F
    Acta Diabetol Lat; 1985; 22(1):25-31. PubMed ID: 3890450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
    Cozzolino D; Sessa G; Salvatore T; Sasso FC; Giugliano D; Lefebvre PJ; Torella R
    J Clin Endocrinol Metab; 1996 Feb; 81(2):713-8. PubMed ID: 8636293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs.
    el-Tayeb KM; Brubaker PL; Vranic M; Lickley HL
    Diabetes; 1985 Dec; 34(12):1293-300. PubMed ID: 2998913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-endorphin-induced hyperglycemia in rabbits: effects of a glucose or arginine challenge.
    Schleicher RL; Chawla RK; Coan PA; Martino-Saltzman D; Collins DC
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E255-9. PubMed ID: 2950769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
    Kaneto A; Kajinuma H; Kaneko T; Kosaka K
    Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of opioid peptides and opiate alkaloids on insulin secretion in the rabbit.
    Rudman D; Berry CJ; Riedeburg CH; Hollins BM; Kutner MH; Lynn MJ; Chawla RK
    Endocrinology; 1983 May; 112(5):1702-10. PubMed ID: 6339212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous opioid modulation of pancreatic hormone secretion: studies in dogs.
    Levin ER; Yamada T; Levin S; Mills S
    Metabolism; 1986 Jan; 35(1):59-63. PubMed ID: 2867455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
    Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
    Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.
    Taborsky GJ; Porte D
    Am J Physiol; 1981 Apr; 240(4):E407-13. PubMed ID: 6111928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An insulin-dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats.
    Chang SL; Lin JG; Chi TC; Liu IM; Cheng JT
    Diabetologia; 1999 Feb; 42(2):250-5. PubMed ID: 10064107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.